Stock Symbol:

BIOD

Company Name:

Biodel, Inc.

Company Description:

Biodel Inc., a development stage biopharmaceutical company, focuses on the development and commercialization of treatments for diabetes. The company develops its product candidates by utilizing its proprietary VIAdel technology that allows to study the interaction between peptide hormones and small molecules.

Investment Sector:

Biotechnology and Drugs

Predicted Split Months:

F-M-A-N

Stock Exchange:

NASDAQ

Predicted Split Price:

$37.00

Predicted Split Ratio:

3 for 2

5 Day Performance After Split:

3.4%

Prior Stock Splits:

0

Stock Split History:

None

Split Predictions Are Based Upon Historical Stock Market Data And Sector Trends. This Data Is For Educational Purposes Only.